Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Tramontano

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|November 10, 2025
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Marcello Arca
Internal and Emergency Medicine|March 1, 2024
Thiazides for the prevention of kidney stone recurrence: are they really effective?Helena Buso, Elena Butera, Daniele Tramontano, et al.
Current Opinion in Lipidology|October 7, 2022
Recent Apolipoprotein CIII trialsDaniele Tramontano, Simone Bini, Laura D'Erasmo, et al.
Internal and Emergency Medicine|May 18, 2026
Targeting triglycerides for cardiovascular risk reductionCarlo Maiorca, Daniele Tramontano, Alessia Di Costanzo, et al.
Current Atherosclerosis Reports|January 6, 2023
How ANGPTL3 Inhibition Will Help Our Clinical Practice?Simone Bini, Daniele Tramontano, Ilenia Minicocci, et al.
STAR Protocols|October 19, 2024
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatmentSimone Bini, Stella Covino, Ilenia Minicocci, et al.
Frontiers in Medicine|February 3, 2022
Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case ReportCarlo Maiorca, Federica Moret, Valentina Martines, et al.
Journal of Clinical Lipidology|June 11, 2025
Lomitapide-induced fatty liver is a reversible condition: Evidence from a case of familial chylomicronemia syndromeDaniele Tramontano, Michele di Martino, Francesco Baratta, et al.
Atherosclerosis|December 21, 2024
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational studyChiara Pavanello, Patrizia Suppressa, Sofia Castiglione, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2026
Low Cholesterol due to APOB Variants: Exploring the Balance Between Liver and Cardiovascular RiskAlessia Di Costanzo, Ilaria Pirona, Silvia Buonaiuto, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Endocrinology, Diabetes, and Obesity|November 10, 2025
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Marcello Arca
Internal and Emergency Medicine|March 1, 2024
Thiazides for the prevention of kidney stone recurrence: are they really effective?Helena Buso, Elena Butera, Daniele Tramontano, et al.
Current Opinion in Lipidology|October 7, 2022
Recent Apolipoprotein CIII trialsDaniele Tramontano, Simone Bini, Laura D'Erasmo, et al.
Internal and Emergency Medicine|May 18, 2026
Targeting triglycerides for cardiovascular risk reductionCarlo Maiorca, Daniele Tramontano, Alessia Di Costanzo, et al.
Current Atherosclerosis Reports|January 6, 2023
How ANGPTL3 Inhibition Will Help Our Clinical Practice?Simone Bini, Daniele Tramontano, Ilenia Minicocci, et al.
STAR Protocols|October 19, 2024
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatmentSimone Bini, Stella Covino, Ilenia Minicocci, et al.
Frontiers in Medicine|February 3, 2022
Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case ReportCarlo Maiorca, Federica Moret, Valentina Martines, et al.
Journal of Clinical Lipidology|June 11, 2025
Lomitapide-induced fatty liver is a reversible condition: Evidence from a case of familial chylomicronemia syndromeDaniele Tramontano, Michele di Martino, Francesco Baratta, et al.
Atherosclerosis|December 21, 2024
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational studyChiara Pavanello, Patrizia Suppressa, Sofia Castiglione, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2026
Low Cholesterol due to APOB Variants: Exploring the Balance Between Liver and Cardiovascular RiskAlessia Di Costanzo, Ilaria Pirona, Silvia Buonaiuto, et al.
Pageof 2